Research Article
IL23R and IL12B SNPs and Haplotypes Strongly Associate with Crohn's Disease Risk in a New Zealand Population
Table 5
The statistical interaction between IL23R SNPs and NOD2 genotype.
| | NOD2 | IL23R | d/d ( = 557) | d/D ( = 95) | D/D ( = 19) | | Control | Case | OR (95% CI) | | Control | Case | OR (95% CI) | | Control | Case |
| rs10889677 | | | | | | | | | | | A/A | 40 | 27 | 0.81 (0.46–1.40) | | 8 | 8 | 0.35 (0.11–1.15) | 0.147 | 0 | 1 | A/C | 130 | 109 | 1.00 | .103 | 12 | 34 | 1.00 | | 2 | 8 | C/C | 156 | 88 | 0.67 (0.47–0.97) | | 14 | 19 | 0.48 (0.19–1.24) | | 0 | 8 |
| rs11209026 | | | | | | | | | | | A/A | 6 | 0 | — | | 0 | 0 | — | | 0 | 0 | A/G | 33 | 22 | 0.95 (0.54–1.68) | .986 | 5 | 2 | 0.20 (0.04–1.08) | 0.061 | 0 | 1 | G/G | 289 | 202 | 1.00 | | 29 | 59 | 1.00 | | 2 | 16 |
| rs11805303 | | | | | | | | | | | C/C | 160 | 94 | 1.00 | | 13 | 18 | 1.00 | 0.056 | 0 | 7 | C/T | 137 | 98 | 1.22 (0.85–1.75) | .140 | 12 | 37 | 2.23 (0.85–5.85) | | 2 | 9 | T/T | 28 | 29 | 1.76 (0.99–3.14) | | 8 | 6 | 0.54 (0.15–1.94) | | 0 | 1 |
| rs1343151 | | | | | | | | | | | A/A | 54 | 10 | 0.23 (0.11–0.47) | | 2 | 4 | 0.94 (0.16–5.69) | 0.615 | 0 | 0 | A/G | 140 | 105 | 0.93 (0.65–1.33) | .0003 | 16 | 22 | 0.65 (0.27–1.55) | | 0 | 9 | G/G | 134 | 108 | 1.00 | | 16 | 34 | 1.00 | | 2 | 8 |
| rs7517847 | | | | | | | | | | | G/G | 64 | 24 | 0.45 (0.26–0.79) | | 4 | 3 | 0.60 (0.12–3.08) | 0.156 | 0 | 0 | G/T | 172 | 121 | 0.84 (0.57–1.24) | .018 | 14 | 36 | 2.06 (0.84–5.07) | | 2 | 6 | T/T | 91 | 76 | 1.00 | | 16 | 20 | 1.00 | | 0 | 10 |
|
|